Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Replacing Coumadin: A $10 Billion Opportunity
Replacing Coumadin: A $10 Billion Opportunity
Replacing Coumadin: A $10 Billion Opportunity
Submitted by
admin
on February 13, 2012 - 7:58pm
Source:
Seeking Alpha
News Tags:
Coumadin
Eliquis
Pfizer
Apixaban
Bristol-Myers Squibb
Xarelto
Bayer
JNJ
Pradaxa
Boehringer Ingelheim
Headline:
Replacing Coumadin: A $10 Billion Opportunity
Do Not Allow Advertisers to Use My Personal information
